NYSE$ASIX
Advansix Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Reported strong volume growth, cash flow generation, cost management and capital discipline.
AdvanSix announced its Q3 2020 financial results, which showed higher cash flow generation while mitigating the ongoing impacts of COVID-19 and executing its planned plant turnaround. Sales were down 9% year-over-year, but volume was up 5%.
- Sales down approximately 9% versus prior year, as 5% higher volume was more than offset by 13% lower raw material pass-through pricing and 1% unfavorable impact of market-based pricing
- Net Loss of ($0.7) million, a decrease of $8.6 million versus the prior year
- Cash Flow from Operations of $35.5 million, an increase of $2.4 million versus the prior year
- Free Cash Flow of $19.6 million, an increase of $21.6 million versus the prior year
Headline financials
Revenue & EPS history
Advansix · Revenue · Quarterly
$282M
Revenue by segment
Advansix · $220M total across 3 segments · Q3 2020
- Chemical Intermediates$95.9M+6.5%43.6%
- Nylon$73.3M-5.6%33.3%
- Caprolactam$50.7M-37.2%23.1%
Forward guidance
AdvanSix provided an outlook including targeting strong caprolactam plant utilization and optimizing nylon mix, expecting a stable ammonium sulfate fertilizer environment, and anticipating a favorable acetone industry supply and demand balance. They also expect continued disciplined cost management and a reduction in net debt and leverage levels.
Tailwinds
- Targeting strong caprolactam plant utilization and optimizing nylon mix across end uses, applications and geographies
- Expect stable ammonium sulfate fertilizer environment to continue through 2020/2021 planting season
- Expect favorable acetone industry supply and demand balance to continue
- Continued disciplined cost management - expect $20 to $25 million full year 2020 cost reduction
- Expect a reduction in net debt and leverage levels in 4Q20 with robust cash generation supported by working capital improvements and cash tax benefits associated with the CARES Act
Headwinds
- Expect pre-tax income impact of planned plant turnarounds to be $25 to $30 million in 2021 (versus approximately $32 million in 2020)
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2020
-0.8%
Avg return
Earnings day
-1.1%
Avg return
5 days after
+0.8%
Avg return
30 days after
52%
23 / 44 earnings
Positive
+15.6%
Q1 2016
Best reaction
-15.5%
Q4 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.1% | -6.6% | — | |
| Q4 2025 | +3.9% | +0.8% | +12.5% | |
| Q3 2025 | -15.0% | -10.9% | -11.7% | |
| Q1 2025 | +6.1% | +6.9% | +10.4% | |
| Q3 2024 | +5.0% | +11.8% | +14.5% | |
| Q2 2024 | +2.7% | +4.0% | +10.5% | |
| Q1 2024 | -9.9% | -6.3% | -8.0% | |
| Q4 2023 | +0.8% | -0.6% | -4.2% | |
| Q3 2023 | -9.5% | -13.2% | -5.0% | |
| Q2 2023 | -8.1% | -5.3% | -14.0% | |
| Q1 2023 | -0.7% | -1.2% | +1.1% | |
| Q4 2022 | -3.3% | -0.9% | -17.7% | |
| Q3 2022 | +3.7% | +1.7% | +14.9% | |
| Q2 2022 | +1.6% | +2.0% | -8.2% | |
| Q1 2022 | -3.9% | -4.2% | -2.2% | |
| Q4 2021 | -11.0% | -14.7% | +30.5% | |
| Q3 2021 | +5.4% | +8.3% | +2.4% | |
| Q2 2021 | +2.6% | +6.9% | +11.5% | |
| Q1 2021 | +3.3% | +6.7% | +3.4% | |
| Q4 2020 | +11.5% | +8.1% | +2.8% | |
| Q3 2020 | +4.4% | -1.3% | +23.6% | |
| Q2 2020 | +1.5% | +5.2% | +16.4% | |
| Q1 2020 | -6.0% | -7.2% | -2.8% | |
| Q4 2019 | -15.5% | -27.0% | -34.1% | |
| Q3 2019 | +3.4% | +4.0% | -11.1% | |
| Q2 2019 | -2.3% | -10.3% | -12.9% | |
| Q1 2019 | +8.1% | +1.6% | -18.7% | |
| Q4 2018 | +2.0% | -1.2% | -15.6% | |
| Q3 2018 | -8.9% | -2.9% | -2.5% | |
| Q2 2018 | -13.2% | -13.5% | -15.0% | |
| Q1 2018 | -5.5% | +2.0% | +2.9% | |
| Q4 2017 | +4.5% | +6.6% | -12.2% | |
| Q3 2017 | -6.7% | -7.2% | -11.4% | |
| Q2 2017 | -4.6% | -4.0% | +3.2% | |
| Q2 2016 | -4.6% | -4.0% | +3.2% | |
| Q1 2017 | +15.6% | +13.7% | +11.3% | |
| Q1 2016 | +15.6% | +13.7% | +11.3% | |
| Q1 2015 | -7.1% | -9.9% | -11.7% | |
| Q2 2015 | -7.1% | -9.9% | -11.7% | |
| Q4 2014 | -7.1% | -9.9% | -11.7% | |
| Q4 2016 | +1.3% | -2.2% | +1.3% | |
| Q4 2015 | +8.5% | +6.9% | +30.4% | |
| Q3 2016 | +8.5% | +6.9% | +30.4% | |
| Q3 2015 | +8.5% | +6.9% | +30.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro